SEC Form 3
FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 11/26/2021 | 3. Issuer Name and Ticker or Trading Symbol ZIMMER BIOMET HOLDINGS, INC. [ ZBH ] | |||||||||||||
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 915.997 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (right to buy) | (1) | 06/24/2025 | Common Stock | 9,445 | 113.83 | D | |
Employee Stock Option (right to buy) | (1) | 03/21/2026 | Common Stock | 10,680 | 104.01 | D | |
Employee Stock Option (right to buy) | (1) | 03/21/2027 | Common Stock | 8,725 | 121.88 | D | |
Employee Stock Option (right to buy) | (1) | 02/20/2028 | Common Stock | 9,805 | 119.61 | D | |
Employee Stock Option (right to buy) | (2) | 03/20/2028 | Common Stock | 8,335 | 114.44 | D | |
Employee Stock Option (right to buy) | (3) | 02/26/2029 | Common Stock | 6,533 | 123.73 | D | |
Employee Stock Option (right to buy) | (4) | 02/21/2030 | Common Stock | 7,133 | 157.54 | D | |
Employee Stock Option (right to buy) | (5) | 02/25/2031 | Common Stock | 5,088 | 163.79 | D |
Explanation of Responses: |
1. Fully vested. |
2. 6,252 options are vested; the remaining 2,083 options vest on March 20, 2022. |
3. 3,267 options are vested; the remaining 3,266 options vest as follows: 1,633 options vest on February 26, 2022 and 1,633 options vest on February 26, 2023. |
4. 1,784 options are vested; the remaining 5,349 options vest as follows: 1,783 options vest on February 21, 2022, 1,783 options vest on February 21, 2023 and 1,783 options vest on February 21, 2024. |
5. Options vest annually over four years in increments of 25% each year, commencing on February 25, 2022. |
Remarks: |
Exhibit 24 - Power of Attorney |
Heather Kidwell, Attorney-in-Fact for Derek M. Davis | 12/06/2021 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |